Alpesh Desai
Dermatology · Houston, TXNPI 1386696904
Payments from drug & device makers
Across 1,324 payments — averaging $2057.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Skye Orthobiologics LLC$573K
- AbbVie$469K
- Novartis$438K
- Regeneron Healthcare Solutions, Inc.$291K
- Pfizer$194K
- Sanofi$152K
- plus $608K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Skye Orthobiologics LLC | 1 | $573,060 |
| AbbVie(2 entities) | 400 | $468,637 |
| Novartis | 221 | $437,522 |
| Regeneron Healthcare Solutions, Inc. | 227 | $291,067 |
| Pfizer | 54 | $194,206 |
| Sanofi | 98 | $152,105 |
| Janssen Scientific Affairs, LLC | 65 | $109,089 |
| Janssen Research & Development, LLC | 20 | $90,305 |
| Sanofi US Services Inc. | 17 | $81,818 |
| Regeneron | 45 | $74,938 |
| UCB SA | 3 | $65,222 |
| Boehringer Ingelheim | 4 | $45,250 |
| Johnson & Johnson | 62 | $38,154 |
| E.r. Squibb & Sons, L.L.C. | 19 | $35,232 |
| Avita Medical Americas, LLC | 2 | $24,350 |
| Argenx US, Inc. | 5 | $15,500 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14,000 |
| Sun Pharmaceutical Industries Inc. | 20 | $10,125 |
| Incyte Corporation | 24 | $2,559 |
| Boehringer Ingelheim RCV GmbH & Co KG | 2 | $649 |
| LEO Pharma Inc. | 4 | $210 |
| Arcutis Biotherapeutics, Inc. | 5 | $110 |
| Revance Therapeutics, Inc. | 1 | $107 |
| Strata Skin Sciences, Inc. | 6 | $84 |
| Galderma Laboratories, L.p. | 5 | $81 |
| Amgen | 4 | $77 |
| Organon | 2 | $29 |
| UCB, Inc. | 1 | $22 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $22 |
| Biofrontera Inc. | 1 | $21 |
| DUSA Pharmaceuticals, Inc. | 1 | $19 |
| Botanix SB Inc | 1 | $17 |
| Dermavant Sciences, Inc. | 1 | $15 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$2,724,616 in reported general payments places this provider in the 95th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Houston
- Michael MigdenHouston$3.7M
- Megan CouvillionHouston$3M
- Suzanne BruceHouston$2.2M
- Geeta PatelHouston$626K
- Madeleine DuvicHouston$597K
- Auris HuenHouston$323K
- Catherine PapasakelariouHouston$289K
- Anisha PatelHouston$268K
- Stephen TyringWebster$14.1M
- Edward LainAustin$12M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.